X. Long Zheng: Novel Gain-of-Function ADAMTS13 Variant with Potential Therapeutic Impact
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press in the Journal of Thrombosis and Haemostasis (JTH) from Szumam Liu et al. about a novel gain-of-funtion ADAMTS13 variant that may have therapeutic implications.
Thank you all for your hardworking and close collaboration.”
Title: ADAMTS13 R1206K Variant Exhibits an Open Conformation and Enhanced Proteolytic Activity toward von Willebrand factor
Authors: Szumam Liu, Xiaxin Dong, Quintijn Bonnez, Zhirong Chai, Chan Meng, Madison Gil, Karen Vanhoorelbeke, Konstantine Halkidis, X. Long Zheng
Read the Full Article on Journal of Thrombosis and Haemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 07:11Platelet Dependent Protection Against Bacterial Pneumonia – JTH
-
Sep 22, 2026, 07:10Sumita Pandey: Apheresis Beyond Automation
-
Sep 22, 2026, 07:04Wafik El-Deiry: Type 1 interferon Alters Clonal Competition in Human Blood Development
-
Sep 22, 2026, 06:53Tania L.: Women in Hematology Take the Stage in Austin
-
Sep 22, 2026, 06:35Mahmoud Hanafy: Hayat National Hospitals Achieves AABB Accreditation
-
Sep 22, 2026, 06:01Nikola Pantic: New ASH ITP Guidelines Transform First-Line Treatment
-
Sep 22, 2026, 04:43Michael Cahillane: Highlights From BBTS2026 in Glasgow
-
Sep 22, 2026, 04:15Wolfgang Miesbach: First AAV Gene Therapy Data in Adolescents With Haemophilia B
-
Sep 22, 2026, 04:03Emmanuel J Favaloro: 100 Years of VWD – A Special Virtual Issue